Revvity, NEV20005, IVISense Oncology Fluorescent Imaging Panel

Cancer arises when cells spontaneously lose control over their growth and division. However, its biology extends far beyond tumor cells alone, encompassing a complex microenvironment of blood vessels, stromal and immune cells, and regions of hypoxia, necrosis, and vascular leak. Our carefully curated IVISense oncology-targeted fluorescent probe panel is designed to quantify key biomarkers linked to tumor burden, metabolism, inflammation, protease activity, and vascular permeability. With options at 680 nm and 750 nm wavelengths, researchers can perform multiplex imaging to extract deeper insights from whole-animal models.